Visceral Leishmaniasis: Integrated In Silico Screening of Djiboutian Medicinal Plant Phytoconstituents Targeting Leishmania donovani and Leishmania infantum
Pharmaceuticals · 06.05.2026 · 19 (5) · 730
DOI: 10.3390/ph19050730 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 06.05.2026. Verfasst von Fatouma Mohamed Abdoul-Latif und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Research Institute, Center for Research and Study of Djibouti, Djibouti City BP 486, Djibouti. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Centre for Genetic Engineering and Biotechnology.
Abstract (Originalsprache)
Objectives
Visceral leishmaniasis (VL), caused by Leishmania donovani and Leishmania infantum, is a life-threatening neglected tropical disease, particularly in endemic regions such as Djibouti. Current therapies are constrained by toxicity, high cost, and limited availability, highlighting the urgent need for safe, effective, and affordable alternatives. This study aimed to identify novel antileishmanial candidates from Djiboutian medicinal plants using an integrated in silico approach.
Methods
A total of 136 phytoconstituents isolated from local medicinal plants were screened via molecular docking against validated protein targets (6UAK and 2JK6). Promising candidates were further analyzed for interaction patterns, drug-likeness according to Lipinski’s Rule of Five, and ADMET properties. Molecular dynamics (MD) simulations over 100 ns were performed to assess the structural stability of selected protein–ligand complexes.
Results
Compound C41 emerged as a leading candidate, showing binding affinities of −8.3 kcal/mol and −7.5 kcal/mol toward 6UAK and 2JK6, respectively, comparable to reference drugs. Interaction analysis revealed stable hydrogen bonds and hydrophobic contacts within the catalytic sites. Drug-likeness assessment confirmed compliance with Lipinski’s Rule, while ADMET predictions indicated high intestinal absorption and favorable safety profiles for several candidates. MD simulations corroborated the structural stability of the 2JK6-C41 complex throughout the 100 ns trajectory.
Conclusions
These findings underscore Djiboutian medicinal plants as a valuable source of potential antileishmanial leads. Among them, Compound C41 represents a promising candidate for future experimental validation, supporting the development of innovative, safe, and cost-effective therapies against visceral leishmaniasis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medicinal Research Institute, Center for Research and Study of Djibouti, Djibouti City BP 486, Djibouti.
- Laboratory of Analytical and Molecular Chemistry, Faculty of Sciences Ben M'Sick, Hassan II University of Casablanca, Casablanca 20670, Morocco.
- CHU Peltier Hospital of Djibouti, Djibouti City P.O. Box 2123, Djibouti.
- International Centre for Genetic Engineering and Bio-Technology, Aruna Asaf Ali Marg, New Delhi 110067, India.
ORCID-Profile: Fatouma Mohamed Abdoul-Latif, Imane Yamari, Pannaga Pavan Jutur, Samir Chtita
Förderung
- International Centre for Genetic Engineering and Biotechnology
Zitieren
APA
Mohamed Abdoul-Latif, F., Bouribab, A., Mohamed, H., El Bouamri, L., Rossafi, B., Guerguer, F., Yamari, I., Ismael, Y. A., Jutur, P. P., & Chtita, S. (2026). Visceral Leishmaniasis: Integrated In Silico Screening of Djiboutian Medicinal Plant Phytoconstituents Targeting Leishmania donovani and Leishmania infantum. Pharmaceuticals, 19(5), 730. https://doi.org/10.3390/ph19050730
Vancouver
Mohamed Abdoul-Latif F, Bouribab A, Mohamed H, El Bouamri L, Rossafi B, Guerguer F, et al. Visceral Leishmaniasis: Integrated In Silico Screening of Djiboutian Medicinal Plant Phytoconstituents Targeting Leishmania donovani and Leishmania infantum. Pharmaceuticals. 2026;19(5):730. doi:10.3390/ph19050730
BibTeX
@article{MohamedAbdoulLatif2026,
author = {Mohamed Abdoul-Latif, Fatouma and Bouribab, Amal and Mohamed, Houda and El Bouamri, Lamiae and Rossafi, Bouchra and Guerguer, Fatimazahra and Yamari, Imane and Ismael, Yahya Ali and Jutur, Pannaga Pavan and Chtita, Samir},
title = {Visceral Leishmaniasis: Integrated In Silico Screening of Djiboutian Medicinal Plant Phytoconstituents Targeting Leishmania donovani and Leishmania infantum},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {5},
pages = {730},
doi = {10.3390/ph19050730}
}
EUVIMED